Delivery Order SPE2DB20D2104-SPE2DB22FT45V
- Not listed
- This federal contract award is for the delivery of Lantus Solostar insulin pens to the Defense Logistics Agency (DLA), a defense agency. The $1,022.80 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a period of performance through December 3, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop...
- This federal contract award is for the delivery of Lantus SoloStar 100 unit/ml 3ml insulin pens to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The contract, worth $1,570.29, was awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of October 28, 2024. This award is not associated with any set-aside program. AmerisourceBergen holds a...
- This federal contract award is for the delivery of Lantus Solostar insulin pens to the Defense Logistics Agency (DLA). The $1,469.00 firm fixed-price delivery order was issued to the prime contractor, AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a wide range of pharmaceutical products...
- This federal contract award is for the delivery of Lantus Solostar 100 unit/mL 3mL insulin pens to the Defense Logistics Agency (DLA). The $1,462.71 fixed-price delivery order was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, under the company's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This IDC serves as a primary vehicle for Amerisourcebergen to provide a wide range of pharmaceutical products and medical supplies to support...
- This federal contract award is for the delivery of Lantus Solostar 100 unit/ml 3ml insulin pens to the Defense Logistics Agency (DLA) Troop Support Medical. The $11,095.12 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on September 26, 2024 with an ultimate completion date of September 27, 2024. The contract was not subject to any set-aside requirements. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award is for the delivery of Lantus Solostar 100 unit/mL 3mL insulin pens, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,187.60 firm-fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, valued up to $999,999,999 through November 2026. This IDC serves as the primary vehicle for AmerisourceBergen to supply a wide...
- This federal contract award is for the delivery of Lantus Solostar 100 unit/mL 3mL insulin pens to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, as a delivery order valued at $2,888.72 with a completion date of February 6, 2024. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent...
- This federal contract award is for the provision of Lantus Solostar 100 unit/ml 3ml insulin pens to the Department of Defense (DoD) Medical Supply Chain, a component of the Defense Logistics Agency (DLA). The $1,187.60 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on June 18, 2024, with a period of performance through June 20, 2024. This award is associated with Amerisourcebergen's $999,999,999.00 Indefinite Delivery...
- This federal contract award to AmerisourceBergen Drug Corp is a delivery order valued at $2,501.97 for the supply of Lantus SoloStar 100 unit/mL 3mL insulin pens. The contract is held under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC enables AmerisourceBergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military...
- This federal contract award is for the delivery of Lantus SoloStar 100 unit/ml 3ml insulin pens to the Defense Logistics Agency (DLA). The $1,290.16 firm-fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distributor Cencora, Inc. The contract has a period of performance through May 20, 2022 and was competitively awarded without any set-aside designation. Amerisourcebergen holds two significant Indefinite Delivery Contracts (IDCs) related to...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB22FT45VDelivery Order
This federal contract award is for the delivery of Lantus Solostar insulin pens to the Defense Logistics Agency (DLA). The $2,016.85 firm-fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of August 1, 2022. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at $999,999,999 and running through November 2026. The IDC covers a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 7/29/22 |